Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-002-158 in Chinese Adult Subjects With Atopic Dermatitis
NCT06931990Phase 2Recruiting
- Sponsor
- Leadingtac
- Start
- Jun 2025
- Primary completion
- Feb 2028
- Modality
- Bivalent/Multivalent Binders, PROTACs (E3 ligase recruitment)
- Countries
- 1
01
Overview
A Phase 2 trial of LT-002 in atopic dermatitis (AD), sponsored by Leadingtac. Started Jun 2025; status: recruiting.
02
Drugs
LT-002
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT06931990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06931990.